{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:11:28Z","timestamp":1792239088982,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1007\/bf02700029","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T01:51:50Z","timestamp":1190080310000},"page":"147-154","source":"Crossref","is-referenced-by-count":76,"title":["Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene \u2014 a phase I\/II clinical protocol"],"prefix":"10.1007","volume":"64","author":[{"given":"H.","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Boulikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"S\u00f6ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. C.","family":"Warnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. G.","family":"Rainov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02700029_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00006123-200008000-00070","volume":"47","author":"PM Black","year":"2000","unstructured":"Black PM: Surgery for cerebral gliomas: past, present, and future. Clin Neurosurg 47: 21\u201345, 2000","journal-title":"Clin Neurosurg"},{"key":"BF02700029_CR2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3171\/jns.1988.69.4.0506","volume":"69","author":"LG Salford","year":"1988","unstructured":"Salford LG, Brun A, Nirfalk S: Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg 69: 506\u2013509, 1988","journal-title":"J Neurosurg"},{"key":"BF02700029_CR3","first-page":"38","volume":"13","author":"WR Shapiro","year":"1986","unstructured":"Shapiro WR: Therapy of adult malignant brain tumors: what have the clinical trials taught us? Semin Oncol 13: 38\u201345, 1986","journal-title":"Semin Oncol"},{"key":"BF02700029_CR4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1227\/00006123-198711000-00001","volume":"21","author":"M Ammirati","year":"1987","unstructured":"Ammirati M, Galicich JH, Arbit E, Liao Y: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21: 607\u2013614, 1987","journal-title":"Neurosurgery"},{"key":"BF02700029_CR5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/0959-8049(94)00248-4","volume":"12","author":"B Rajan","year":"1994","unstructured":"Rajan B, Ross G, Lim CC, Ashley S, Goode D, Traish D, Brada M: Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. Eur J Cancer 12: 1809\u20131815, 1994","journal-title":"Eur J Cancer"},{"key":"BF02700029_CR6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0952-7915(00)00144-8","volume":"12","author":"N Mach","year":"2000","unstructured":"Mach N, Dranoff G: Cytokine-secreting tumor cell vaccines. Curr Opin Immunol 12: 571\u2013575, 2000","journal-title":"Curr Opin Immunol"},{"key":"BF02700029_CR7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/mthe.2000.0101","volume":"2","author":"A Niranjan","year":"2000","unstructured":"Niranjan A, Moriuchi S, Lunsford LD, Kondziolka D, Flickinger JC, Fellows W, Rajendiran S, Tamura M, Cohen JB, Glorioso JC: Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration. Mol Ther 2: 114\u2013120, 2000","journal-title":"Mol Ther"},{"key":"BF02700029_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1359-6101(96)00052-4","volume":"8","author":"A Mackensen","year":"1997","unstructured":"Mackensen A, Lindemann A, Martelsmann R: Immuno-stimulatory cytokines in somatic cells and gene therapy of cancer. Cytokine Growth Factor Rev 8: 119\u2013128, 1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"BF02700029_CR9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1525-1438.2002.01060.x","volume":"12","author":"HN Qian","year":"2002","unstructured":"Qian HN, Liu GZ, Cao SJ, Feng J, Ye X: Experimental study of ovarian carcinoma vaccine modified by human B7-1 and IFN-gamma genes. Int J Gynecol Cancer 12: 80\u201385, 2002","journal-title":"Int J Gynecol Cancer"},{"key":"BF02700029_CR10","first-page":"1","volume":"1","author":"T Boulikas","year":"1998","unstructured":"Boulikas T: Status of gene therapy in 1997: molecular mechanisms, disease targets, and clinical applications. Gene Ther Mol Biol 1: 1\u2013172, 1998","journal-title":"Gene Ther Mol Biol"},{"key":"BF02700029_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1172\/JCI200110128","volume":"108","author":"JM Wigginton","year":"2001","unstructured":"Wigginton JM, Gruys E, Geiselhart L, Subleski J, Komschlies KL, Park JW, Wiltrout TA, Nagashima K, Back TC, Wiltrout RH: IFN-gamma and Fas\/FasL are required for the antitumor and antiangiogenic effects of IL-12\/pulse IL-2 therapy. J Clin Invest 108: 51\u201362, 2001","journal-title":"J Clin Invest"},{"key":"BF02700029_CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(01)00032-6","volume":"13","author":"MP Colombo","year":"2002","unstructured":"Colombo MP, Trinchieri G: Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13: 155\u2013168, 2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"BF02700029_CR13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cgt.7700399","volume":"9","author":"Y Liu","year":"2002","unstructured":"Liu Y, Ehtesham M, Samoto K, Wheeler CJ, Thompson RC, Villarreal LP, Black KL, Yu JS:In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma. Cancer Gene Ther 9: 9\u201315, 2002","journal-title":"Cancer Gene Ther"},{"key":"BF02700029_CR14","first-page":"57","volume":"238","author":"G Trinchieri","year":"1999","unstructured":"Trinchieri G, Scott P: Interleukin-12: basic principles and clinical applications. Curr Top Microbiol Immunol 238: 57\u201378, 1999","journal-title":"Curr Top Microbiol Immunol"},{"key":"BF02700029_CR15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/sj.gt.3300841","volume":"6","author":"C Asselin-Paturel","year":"1999","unstructured":"Asselin-Paturel C, Lassau N, Guinebretiere JM, Zhang J, Gay F, Bex F, Hallez S, Leclere J, Peronneau P, Mami-Chouaib F, Chouaib S: Transfer of the murine interleukin-12 genein vivo by a Semliki forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography. Gene Ther 6: 606\u2013615, 1999","journal-title":"Gene Ther"},{"key":"BF02700029_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/08820130009062298","volume":"29","author":"SF Wolf","year":"2000","unstructured":"Wolf SF, Lee K, Swiniarski H, O\u2019Toole M, Sturmhoefel K: Cytokines and cancer immunotherapy. Immunol Invest 29: 143\u2013146, 2000","journal-title":"Immunol Invest"},{"key":"BF02700029_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.1997.6388","volume":"233","author":"S Hiscox","year":"1997","unstructured":"Hiscox S, Jiang WG: Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor\/scatter factor. Biochem Biophys Res Commun 233: 1\u20135, 1997","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02700029_CR18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1096-9098(199806)68:2<122::AID-JSO10>3.0.CO;2-4","volume":"68","author":"ML Salgaller","year":"1998","unstructured":"Salgaller ML, Lodge PA: Use of cellular and cytokine adjuvants in the immunotherapy of cancer. J Surg Oncol 68: 122\u2013138, 1998","journal-title":"J Surg Oncol"},{"key":"BF02700029_CR19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/86297","volume":"2","author":"MJ Smyth","year":"2001","unstructured":"Smyth MJ, Godfrey DI, Trapani JA: A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2: 293\u2013299, 2001","journal-title":"Nat Immunol"},{"key":"BF02700029_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/foc.2000.9.6.8","volume":"9","author":"R Yamanaka","year":"2000","unstructured":"Yamanaka R, Zullo SA, Tanaka R, et al.: Induction of a therapic antitumor immunological response by intratumoral injection of genetically engineered Semliki forest virus to produce IL-12. Neurosurg Focus 9: 1\u20136, 2000","journal-title":"Neurosurg Focus"},{"key":"BF02700029_CR21","first-page":"23","volume":"4","author":"K Lundstrom","year":"1999","unstructured":"Lundstrom K, Schweitzer C, Richards JG, Ehrengruber MU, Jenck F, M\u00fclhardt C: Semliki forest virus vectors forin vitro andin vivo applications. Gene Ther Mol Biol 4: 23\u201331, 1999","journal-title":"Gene Ther Mol Biol"},{"key":"BF02700029_CR22","first-page":"25","volume":"6","author":"K Lundstrom","year":"2001","unstructured":"Lundstrom K: Novel developments for applications of alphavirus vectors in gene therapy. Gene Ther Mol Biol 6: 25\u201331, 2001","journal-title":"Gene Ther Mol Biol"},{"key":"BF02700029_CR23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000053992","volume":"43","author":"K Lundstrom","year":"2000","unstructured":"Lundstrom K: Alphavirus vectors: applications for DNA vaccine production and gene expression. Intervirology 43: 247\u2013257, 2000","journal-title":"Intervirology"},{"key":"BF02700029_CR24","first-page":"241","volume":"5","author":"PA Hardy","year":"2000","unstructured":"Hardy PA, Mazzini MJ, Schweitzer C, Lundstrom K, Glode LM: Recombinant Semliki forest virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cellsex vivo. Int J Mol Med 5: 241\u2013245, 2000","journal-title":"Int J Mol Med"},{"key":"BF02700029_CR25","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.gt.3301263","volume":"7","author":"A-M Murphy","year":"2000","unstructured":"Murphy A-M, Morris-Downes MM, Sheahan BJ, Atkins GJ: Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki forest virus recombinant particles. Gene Ther 7: 1477\u20131482, 2000","journal-title":"Gene Ther"},{"key":"BF02700029_CR26","first-page":"15","volume":"3","author":"K Lundstrom","year":"1999","unstructured":"Lundstrom K, Richards JG, Pink JR, Jenck F: Efficientin vivo expression of a reporter gene in rat brain after injection of recombinant replication-deficient Semliki forest virus. Gene Ther Mol Biol 3: 15\u201323, 1999","journal-title":"Gene Ther Mol Biol"},{"key":"BF02700029_CR27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3171\/jns.2001.94.3.0474","volume":"94","author":"R Yamanaka","year":"2001","unstructured":"Yamanaka R, Zullo SA, Tanaka R, Blaese M, Xanthopoulos KG: Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA. J Neurosurg 94: 474\u2013481, 2001","journal-title":"J Neurosurg"},{"key":"BF02700029_CR28","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/sj.gt.3301004","volume":"6","author":"P Colmenero","year":"1999","unstructured":"Colmenero P, Liljestr\u00f6m P, Jondal M: Induction of P185 tumor immunity by recombinant Semliki forest virus expressing the P1A gene. Gene Ther 6: 1728\u20131733, 1999","journal-title":"Gene Ther"},{"key":"BF02700029_CR29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/10548","volume":"5","author":"H Ying","year":"1999","unstructured":"Ying H, Zaks TZ, Wang RF, Irvine KR, Kammula US, Marincola FM, Leitner WW, Restifo NP: Cancer therapy using a self-replicating RNA vaccine. Nat Med 5: 823\u2013827, 1999","journal-title":"Nat Med"},{"key":"BF02700029_CR30","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.gt.3301257","volume":"7","author":"T Daemen","year":"2000","unstructured":"Daemen T, Pries F, Bungener L, Kraak M, Regts J, Wilschut J: Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16E6 and E7. Gene Ther 7: 1859\u20131866, 2000","journal-title":"Gene Ther"},{"key":"BF02700029_CR31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02762410","volume":"5","author":"GJ Atkins","year":"1996","unstructured":"Atkins GJ, Sheahan BJ, Liljestrom P: Manipulation of the Semliki forest virus genome and its potential for vaccine construction. Mol Biotechnol 5: 33\u201338, 1996","journal-title":"Mol Biotechnol"},{"key":"BF02700029_CR32","first-page":"173","volume":"1","author":"F Martin","year":"1998","unstructured":"Martin F, Boulikas T: The challenge of liposomes in gene therapy. Gene Ther Mol Biol 1: 173\u2013214, 1998","journal-title":"Gene Ther Mol Biol"}],"container-title":["Journal of Neuro-oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02700029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02700029\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02700029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T19:37:14Z","timestamp":1558208234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02700029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["BF02700029"],"URL":"https:\/\/doi.org\/10.1007\/bf02700029","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}